• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

瑞典南部一县社区和医院环境中产 ESBL 粪便携带情况的流行率。

Prevalence of faecal ESBL carriage in the community and in a hospital setting in a county of Southern Sweden.

机构信息

Infectious Diseases Unit, Department of Clinical Sciences, Lund University, Malmö, Sweden.

出版信息

Eur J Clin Microbiol Infect Dis. 2011 Oct;30(10):1159-62. doi: 10.1007/s10096-011-1202-5. Epub 2011 Mar 12.

DOI:10.1007/s10096-011-1202-5
PMID:21399889
Abstract

The aim of this study was to investigate the prevalence of extended-spectrum beta-lactamase (ESBL)-producing bacteria in patients at various hospital wards and in a group of relatively healthy volunteers, in order to obtain greater knowledge on how common these bacterial strains are in hospital settings and in the general community. Participants (n = 427) were enrolled at a University Hospital and at Primary Health Care Units (PHCUs) in Sweden in 2008 and 2010. The participants provided rectal swabs, which were tested for the occurrence of ESBL-producing bacteria. Positive samples were analysed with polymerase chain reaction (PCR) methods for bacterial strain typing and ESBL phylogroups. In 2008, the prevalence was 2.1% (2/96) in PHCU subjects and 1.8% (2/113) in hospital patients. In 2010, the prevalence was 3.0% (3/100) in PHCU subjects and 6.8% (8/118) in hospital patients. The dominating phylogroups were CTX-M-1 and CTX-M-9. All ESBL-positive isolates were Escherichia coli. We found a higher prevalence of ESBL faecal carriage than expected, both in the hospital setting and in the PHCU group.

摘要

本研究旨在调查不同医院病房和一组相对健康的志愿者中,产extended-spectrum beta-lactamase (ESBL)的细菌的流行情况,以便更深入地了解这些细菌在医院环境和普通社区中的普遍程度。参与者(n=427)于 2008 年和 2010 年在瑞典的一所大学医院和基层医疗单位(PHCUs)招募。参与者提供直肠拭子,检测产 ESBL 的细菌。对阳性样本进行聚合酶链反应(PCR)方法分析,以进行细菌株分型和 ESBL phylogroups 分析。2008 年,PHCU 组的流行率为 2.1%(2/96),医院患者为 1.8%(2/113)。2010 年,PHCU 组的流行率为 3.0%(3/100),医院患者为 6.8%(8/118)。主要 phylogroups 为 CTX-M-1 和 CTX-M-9。所有 ESBL 阳性分离株均为大肠杆菌。我们发现,无论是在医院环境还是 PHCU 组,产 ESBL 的粪便携带率都高于预期。

相似文献

1
Prevalence of faecal ESBL carriage in the community and in a hospital setting in a county of Southern Sweden.瑞典南部一县社区和医院环境中产 ESBL 粪便携带情况的流行率。
Eur J Clin Microbiol Infect Dis. 2011 Oct;30(10):1159-62. doi: 10.1007/s10096-011-1202-5. Epub 2011 Mar 12.
2
Nationwide high prevalence of CTX-M and an increase of CTX-M-55 in Escherichia coli isolated from patients with community-onset infections in Chinese county hospitals.在中国县级医院社区获得性感染患者分离出的大肠杆菌中,CTX-M在全国范围内具有高流行率且CTX-M-55有所增加。
BMC Infect Dis. 2014 Dec 3;14:659. doi: 10.1186/s12879-014-0659-0.
3
Fecal carriage of extended-spectrum β-lactamases and AmpC-producing Escherichia coli in a Libyan community.利比亚某社区中产超广谱β-内酰胺酶和产AmpC酶大肠埃希菌的粪便携带情况
Ann Clin Microbiol Antimicrob. 2014 Jun 16;13:22. doi: 10.1186/1476-0711-13-22.
4
Risk factors for, and clinical relevance of, faecal extended-spectrum β-lactamase producing Escherichia coli (ESBL-EC) carriage in neutropenic patients with haematological malignancies.中性粒细胞减少症血液病患者粪便产Extended-spectrum β-lactamase 大肠埃希菌(ESBL-EC)携带的危险因素及其临床相关性。
Eur J Clin Microbiol Infect Dis. 2011 Mar;30(3):355-60. doi: 10.1007/s10096-010-1093-x. Epub 2010 Oct 30.
5
Prevalence and molecular characterization of ESBL/pAmpC producing faecal Escherichia coli strains with widespread detection of CTX-M-15 isolated from healthy poultry flocks in Eastern Algeria.在阿尔及利亚东部的健康家禽群中分离出的广泛存在 CTX-M-15 的产 ESBL/pAmpC 粪便大肠杆菌菌株的流行情况和分子特征。
Microb Pathog. 2024 Nov;196:106973. doi: 10.1016/j.micpath.2024.106973. Epub 2024 Sep 21.
6
10-Fold increase (2006-11) in the rate of healthy subjects with extended-spectrum β-lactamase-producing Escherichia coli faecal carriage in a Parisian check-up centre.在巴黎体检中心,产超广谱β-内酰胺酶大肠埃希菌粪便携带的健康受试者的比率增加了 10 倍(2006-11)。
J Antimicrob Chemother. 2013 Mar;68(3):562-8. doi: 10.1093/jac/dks429. Epub 2012 Nov 9.
7
Faecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology.产超广谱β-内酰胺酶大肠杆菌的粪便携带情况:患病率、危险因素及分子流行病学
J Antimicrob Chemother. 2008 Nov;62(5):1142-9. doi: 10.1093/jac/dkn293. Epub 2008 Jul 18.
8
Fecal Carriage of Enterobacteriaceae Producing Extended-Spectrum Beta-Lactamases in Hospitalized Patients and Healthy Community Volunteers in Burkina Faso.布基纳法索住院患者和健康社区志愿者中产超广谱β-内酰胺酶肠杆菌科细菌的粪便携带情况
Microb Drug Resist. 2017 Jan;23(1):63-70. doi: 10.1089/mdr.2015.0356. Epub 2016 Apr 19.
9
Prevalence of rectal carriage of extended-spectrum beta-lactamase-producing Escherichia coli among elderly people in community settings in China.中国社区老年人中产超广谱β-内酰胺酶大肠埃希菌直肠携带情况
Can J Microbiol. 2008 Sep;54(9):781-5. doi: 10.1139/w08-059.
10
[Investigation of beta-lactamase genes and clonal relationship among the extended-spectrum beta-lactamase producing nosocomial Escherichia coli isolates].产超广谱β-内酰胺酶的医院内分离大肠埃希菌中β-内酰胺酶基因及克隆关系的研究
Mikrobiyol Bul. 2015 Jan;49(1):15-25. doi: 10.5578/mb.8437.

引用本文的文献

1
Six-year antimicrobial resistance patterns of Escherichia coli isolates from different hospitals in Gaza, Palestine.巴勒斯坦加沙不同医院分离出的大肠杆菌的六年抗菌药物耐药模式。
BMC Microbiol. 2025 Aug 29;25(1):559. doi: 10.1186/s12866-025-04335-3.
2
Epidemiology and clinical characteristics of patients with healthcare-acquired multidrug-resistant Gram-negative bacilli: a retrospective study from a tertiary care hospital.医疗机构获得性多重耐药革兰氏阴性杆菌感染患者的流行病学和临床特征:来自一家三级医院的回顾性研究。
Sci Rep. 2024 Feb 6;14(1):3022. doi: 10.1038/s41598-024-53596-x.
3
Comparison of the global prevalence and trend of human intestinal carriage of ESBL-producing between healthcare and community settings: a systematic review and meta-analysis.

本文引用的文献

1
Extended-spectrum beta-lactamase-producing Escherichia coli in patients with travellers' diarrhoea.旅行者腹泻患者中产超广谱β-内酰胺酶的大肠埃希菌
Scand J Infect Dis. 2010 Apr;42(4):275-80. doi: 10.3109/00365540903493715.
2
Strama--a Swedish working model for containment of antibiotic resistance.斯特拉马——瑞典控制抗生素耐药性的工作模式。
Euro Surveill. 2008 Nov 13;13(46):19041.
3
Faecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology.产超广谱β-内酰胺酶大肠杆菌的粪便携带情况:患病率、危险因素及分子流行病学
医疗保健机构与社区环境中产生超广谱β-内酰胺酶的人类肠道携带的全球患病率及趋势比较:一项系统评价和荟萃分析。
JAC Antimicrob Resist. 2022 Jun 2;4(3):dlac048. doi: 10.1093/jacamr/dlac048. eCollection 2022 Jun.
4
Prevalence of multidrug-resistant and extended-spectrum beta-lactamase (ESBL)-producing gram-negative bacilli: A meta-analysis report in Ethiopia.埃塞俄比亚产超广谱β-内酰胺酶(ESBL)和多重耐药革兰氏阴性杆菌的患病率:一项荟萃分析报告
Drug Target Insights. 2020 Oct 5;14:16-25. doi: 10.33393/dti.2020.2170. eCollection 2020.
5
Isolation of Extended-Spectrum -lactamase- (ESBL-) Producing and from Patients with Community-Onset Urinary Tract Infections in Jimma University Specialized Hospital, Southwest Ethiopia.埃塞俄比亚西南部吉马大学专科医院社区获得性尿路感染患者中产超广谱β-内酰胺酶(ESBL)的[具体细菌名称未给出]和[具体细菌名称未给出]的分离
Can J Infect Dis Med Microbiol. 2018 Dec 13;2018:4846159. doi: 10.1155/2018/4846159. eCollection 2018.
6
Characteristics of Carbapenemase-Producing Enterobacteriaceae in Wastewater Revealed by Genomic Analysis.基于基因组分析的污水中产碳青霉烯酶肠杆菌科的特征。
Antimicrob Agents Chemother. 2018 Apr 26;62(5). doi: 10.1128/AAC.02501-17. Print 2018 May.
7
Occurrence of Clinically Important Lineages, Including the Sequence Type 131 C1-M27 Subclone, among Extended-Spectrum-β-Lactamase-Producing Escherichia coli in Wastewater.污水中产超广谱β-内酰胺酶大肠杆菌中包括序列型 131 C1-M27 亚克隆在内的临床重要谱系的出现。
Antimicrob Agents Chemother. 2017 Aug 24;61(9). doi: 10.1128/AAC.00564-17. Print 2017 Sep.
8
Evaluation of MLVA for epidemiological typing and outbreak detection of ESBL-producing Escherichia coli in Sweden.瑞典用于产超广谱β-内酰胺酶大肠埃希菌的流行病学分型及暴发检测的多位点可变数目串联重复序列分析评估
BMC Microbiol. 2017 Jan 6;17(1):8. doi: 10.1186/s12866-016-0922-1.
9
Carriage of ESBL/AmpC-producing or ciprofloxacin non-susceptible and spp. in healthy people in Norway.挪威健康人群中携带产超广谱β-内酰胺酶/头孢菌素酶或对环丙沙星不敏感的细菌及相关菌种的情况。
Antimicrob Resist Infect Control. 2016 Dec 15;5:57. doi: 10.1186/s13756-016-0156-x. eCollection 2016.
10
Uropathogen distribution and antimicrobial susceptibility in uncomplicated cystitis in Belgium, a high antibiotics prescribing country: 20-year surveillance.比利时一个抗生素高处方率国家单纯性膀胱炎的尿路病原体分布及抗菌药物敏感性:20年监测
Eur J Clin Microbiol Infect Dis. 2017 Jan;36(1):105-113. doi: 10.1007/s10096-016-2776-8. Epub 2016 Sep 17.
J Antimicrob Chemother. 2008 Nov;62(5):1142-9. doi: 10.1093/jac/dkn293. Epub 2008 Jul 18.
4
Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern.产超广谱β-内酰胺酶肠杆菌科细菌:一个新出现的公共卫生问题。
Lancet Infect Dis. 2008 Mar;8(3):159-66. doi: 10.1016/S1473-3099(08)70041-0.
5
Breakpoints for intravenously used cephalosporins in Enterobacteriaceae--EUCAST and CLSI breakpoints.肠杆菌科中静脉使用头孢菌素的折点——欧洲抗菌药物敏感性试验委员会(EUCAST)和美国临床和实验室标准协会(CLSI)的折点
Clin Microbiol Infect. 2008 Jan;14 Suppl 1:169-74. doi: 10.1111/j.1469-0691.2007.01856.x.
6
Extended-spectrum beta-lactamases: a clinical update.超广谱β-内酰胺酶:临床最新进展
Clin Microbiol Rev. 2005 Oct;18(4):657-86. doi: 10.1128/CMR.18.4.657-686.2005.
7
Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes.产超广谱β-内酰胺酶的大肠埃希菌和肺炎克雷伯菌:感染的危险因素及耐药性对结局的影响
Clin Infect Dis. 2001 Apr 15;32(8):1162-71. doi: 10.1086/319757. Epub 2001 Mar 26.
8
Evolution of extended-spectrum beta-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia.一株大肠杆菌在多次菌血症发作期间超广谱β-内酰胺耐药性(SHV-8)的演变
Antimicrob Agents Chemother. 1997 Mar;41(3):647-53. doi: 10.1128/AAC.41.3.647.